YieldMax MRNA Option Income Strategy ETF

Frequently Asked Questions About MRNY

What does MRNY invest in?

This actively managed exchange-traded fund, known as the YieldMax MRNA Option Income Strategy ETF (MRNY), is engineered to deliver consistent weekly income. It achieves this by strategically issuing call options or initiating call spreads that are tied to shares of MRNA. The fundamental design of this approach is to collect premiums from these options, while also providing investors with a means to participate in any upward movement in MRNA's stock valuation.

What is the expense ratio of MRNY?

YieldMax MRNA Option Income Strategy ETF (MRNY) charges an expense ratio of 1.00%. This is the annual fee deducted from fund assets to cover management and operations.

What is MRNY's distribution yield?

MRNY's trailing-twelve-month yield is 44.41%, calculated from the sum of distributions over the past year divided by the current price. A rate this high reflects large option-premium distributions against a NAV that has declined over the same period — part of each payout may be return of capital rather than earned income.

How does MRNY's covered-call strategy work?

MRNY sells call options against the stocks (or index) it holds, collecting premium income that gets passed through to shareholders as distributions. The strategy generates above-market income in flat or rising markets but caps upside — when the underlying rallies past the strike, the gains above the strike go to the option buyer, not the fund.

How big is MRNY?

YieldMax MRNA Option Income Strategy ETF (MRNY) manages $144.3M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is MRNY actively managed or an index fund?

MRNY's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.